Back

ADAT2/3-mediated tRNA editing promotes cancer cell growth and tumorigenicity

Ramirez-Moya, J.; Antika, T. R.; Liu, Q.; Xiong, X.; Ali, R.; Gutierrez, A.; Gregory, R. I.

2024-11-03 cancer biology
10.1101/2024.10.31.621298 bioRxiv
Show abstract

Transfer RNAs (tRNAs) are subject to various chemical modifications that influence their stability or function. Adenosine to Inosine (A-to-I) editing in the tRNA anticodon at position A34 is an important modification that expands anticodon-codon recognition at the wobble position and is required for normal mRNA translation. The relevance of tRNA editing in cancer remains unexplored. Here we show that the genes encoding the ADAT2/3 deaminase complex, responsible for A-to-I tRNA editing in humans, are commonly amplified and/or overexpressed in several tumor types including liposarcoma (LPS). We find that knockdown of the ADAT complex suppresses LPS cell growth and tumorigenicity. Mechanistically, we find that decreased tRNA editing upon ADAT2 depletion leads to defective translation of a subset of mRNAs. Thus, ADAT-mediated tRNA modification promotes oncogenesis by enhancing the translation of growth promoting mRNAs that are enriched in NNC codons that lack cognate tRNAs and therefore depend on A-I tRNA editing for decoding and mRNA translation. Our results uncover an oncogenic role of tRNA editing and identify ADAT2/3 as a potential new cancer therapeutic target.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Cancer Letters
○ 35 papers in training set
Top 0.1%
12.3%
Similar papers in this journal
2
Nucleic Acids Research
◐ 1281 papers in training set
Top 2%
7.8%
Similar papers in this journal
3
Nature Communications
○ 5641 papers in training set
Top 24%
6.6%
Similar papers in this journal
4
Oncogene
○ 85 papers in training set
Top 0.4%
4.3%
Similar papers in this journal
5
eLife
● 5828 papers in training set
Top 29%
4.3%
Similar papers in this journal
6
Molecular and Cellular Biology
○ 47 papers in training set
Top 0.1%
4.0%
7
Cancers
○ 213 papers in training set
Top 2%
4.0%
8
NAR Cancer
◐ 37 papers in training set
Top 0.1%
4.0%
9
Science Advances
● 1243 papers in training set
Top 14%
2.6%
10
Oncogenesis
○ 12 papers in training set
Top 0.1%
2.4%
50% of probability mass above
11
Genome Biology
○ 637 papers in training set
Top 5%
2.4%
12
Cancer Gene Therapy
○ 11 papers in training set
Top 0.1%
2.1%
13
Cancer Research
● 130 papers in training set
Top 2%
2.1%
14
PLOS Genetics
● 862 papers in training set
Top 6%
2.1%
15
Cell Reports
○ 1498 papers in training set
Top 17%
2.1%
16
Molecular Cancer
○ 16 papers in training set
Top 0.1%
1.9%
17
The EMBO Journal
○ 309 papers in training set
Top 3%
1.7%
18
Communications Biology
○ 993 papers in training set
Top 16%
1.7%
19
Molecular Therapy
○ 81 papers in training set
Top 1.0%
1.7%
20
Molecular Oncology
○ 55 papers in training set
Top 0.8%
1.4%
21
PLOS ONE
● 5266 papers in training set
Top 50%
1.4%
22
RNA Biology
○ 78 papers in training set
Top 0.8%
1.3%
23
Scientific Reports
○ 3612 papers in training set
Top 65%
1.1%
24
Cellular and Molecular Life Sciences
○ 96 papers in training set
Top 1%
1.1%
25
Molecular Cancer Research
● 49 papers in training set
Top 1%
1.1%
26
Journal of Biological Chemistry
○ 690 papers in training set
Top 8%
1.1%
27
International Journal of Molecular Sciences
○ 494 papers in training set
Top 12%
1.1%
28
Life Science Alliance
● 285 papers in training set
Top 7%
1.0%
29
BMC Cancer
○ 67 papers in training set
Top 2%
0.9%
30
Cancer Research Communications
● 51 papers in training set
Top 2%
0.8%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.